Cargando…
Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
BACKGROUND: This study aimed to identify potential predictive factors for the survival of advanced non small-cell lung cancer (NSCLC) patients undergoing first-line platinum-based chemotherapy. METHODS: A total of 270 advanced NSCLC patients who underwent first-line platinum-based chemotherapy from...
Autores principales: | Ying, Jun, Zhou, Danfei, Gu, Tongjie, Huang, Jianda, Liu, Haijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441182/ https://www.ncbi.nlm.nih.gov/pubmed/30925910 http://dx.doi.org/10.1186/s12885-019-5490-y |
Ejemplares similares
-
The prognostic value of pretreatment albumin-to-fibrinogen ratio in small cell lung cancer patients receiving first-line platinum-based chemotherapy
por: Li, Qi, et al.
Publicado: (2023) -
Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma
por: Chen, Wei, et al.
Publicado: (2022) -
Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma
por: Zhao, Xin, et al.
Publicado: (2023) -
Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis
por: Sun, Da-wei, et al.
Publicado: (2020) -
Fibrinogen–Albumin-Ratio is an independent predictor of thromboembolic complications in patients undergoing VA-ECMO
por: Roth, Sebastian, et al.
Publicado: (2021)